Cargando…

Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study)

BACKGROUND: Despite the availability of effective treatment, the control of hypertension remains insufficient. Telemonitoring in the management of hypertension would be an effective way to improve blood pressure control. OBJECTIVE: The aim of our study will be to evaluate the effects of telemonitori...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben Hafaiedh, Sonia, Ben Daya, Yosra, Radoui, Amina Hadjer, Bouchoucha, Mohamed, Razgallah, Rabie, Nouira, Semir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924775/
https://www.ncbi.nlm.nih.gov/pubmed/35230254
http://dx.doi.org/10.2196/26184
_version_ 1784669931290230784
author Ben Hafaiedh, Sonia
Ben Daya, Yosra
Radoui, Amina Hadjer
Bouchoucha, Mohamed
Razgallah, Rabie
Nouira, Semir
author_facet Ben Hafaiedh, Sonia
Ben Daya, Yosra
Radoui, Amina Hadjer
Bouchoucha, Mohamed
Razgallah, Rabie
Nouira, Semir
author_sort Ben Hafaiedh, Sonia
collection PubMed
description BACKGROUND: Despite the availability of effective treatment, the control of hypertension remains insufficient. Telemonitoring in the management of hypertension would be an effective way to improve blood pressure control. OBJECTIVE: The aim of our study will be to evaluate the effects of telemonitoring with antihypertensive treatment titration on blood pressure control in Tunisian patients with hypertension. METHODS: Our trial will be a prospective, rater-blinded randomized controlled trial carried out with primary care physicians in the Sahel region of Tunisia. Patients will be eligible for enrollment if they are aged over 35 years, are newly diagnosed with hypertension, or are known to be poorly controlled on antihypertensive therapy. Participants will be randomly assigned in a 1:1 ratio to the telemonitoring arm or usual care arm. The telemonitoring arm will involve a weekly telephone call for the collection of the home blood pressure measurements, therapeutic education, and treatment compliance assessment as well as a monthly call for treatment titration and a side effect check. Randomization will be done via the use of an interactive web responsive system, and patients will be stratified by investigation center. Neither participants nor investigators will be masked to the group assignments. The primary outcome will be the change in mean 24-hour systolic blood pressure from baseline to the 6-month follow-up in the 2 groups. All randomized patients who attend the follow-up visit at 6 months and have no missing data for the primary outcome will be included in the analysis. RESULTS: Recruitment to the trial started in July 2020. The study was initiated with 17 primary care physicians. We expect the inclusion period to last for approximately 6 months. We expect to complete data collection by the end of 2021 and plan to disseminate the results subsequently. CONCLUSIONS: The HOROSCOPE (Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Randomized Controlled Prospective Trial) study will provide important new evidence that could shed some light on the feasibility and impact of telemonitoring and self-monitoring in a Tunisian population of patients with hypertension who consult primary care physicians. TRIAL REGISTRATION: ClinicalTrials.gov NCT04607239; https://clinicaltrials.gov/ct2/show/NCT04607239 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/26184
format Online
Article
Text
id pubmed-8924775
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-89247752022-03-17 Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study) Ben Hafaiedh, Sonia Ben Daya, Yosra Radoui, Amina Hadjer Bouchoucha, Mohamed Razgallah, Rabie Nouira, Semir JMIR Res Protoc Protocol BACKGROUND: Despite the availability of effective treatment, the control of hypertension remains insufficient. Telemonitoring in the management of hypertension would be an effective way to improve blood pressure control. OBJECTIVE: The aim of our study will be to evaluate the effects of telemonitoring with antihypertensive treatment titration on blood pressure control in Tunisian patients with hypertension. METHODS: Our trial will be a prospective, rater-blinded randomized controlled trial carried out with primary care physicians in the Sahel region of Tunisia. Patients will be eligible for enrollment if they are aged over 35 years, are newly diagnosed with hypertension, or are known to be poorly controlled on antihypertensive therapy. Participants will be randomly assigned in a 1:1 ratio to the telemonitoring arm or usual care arm. The telemonitoring arm will involve a weekly telephone call for the collection of the home blood pressure measurements, therapeutic education, and treatment compliance assessment as well as a monthly call for treatment titration and a side effect check. Randomization will be done via the use of an interactive web responsive system, and patients will be stratified by investigation center. Neither participants nor investigators will be masked to the group assignments. The primary outcome will be the change in mean 24-hour systolic blood pressure from baseline to the 6-month follow-up in the 2 groups. All randomized patients who attend the follow-up visit at 6 months and have no missing data for the primary outcome will be included in the analysis. RESULTS: Recruitment to the trial started in July 2020. The study was initiated with 17 primary care physicians. We expect the inclusion period to last for approximately 6 months. We expect to complete data collection by the end of 2021 and plan to disseminate the results subsequently. CONCLUSIONS: The HOROSCOPE (Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Randomized Controlled Prospective Trial) study will provide important new evidence that could shed some light on the feasibility and impact of telemonitoring and self-monitoring in a Tunisian population of patients with hypertension who consult primary care physicians. TRIAL REGISTRATION: ClinicalTrials.gov NCT04607239; https://clinicaltrials.gov/ct2/show/NCT04607239 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/26184 JMIR Publications 2022-03-01 /pmc/articles/PMC8924775/ /pubmed/35230254 http://dx.doi.org/10.2196/26184 Text en ©Sonia Ben Hafaiedh, Yosra Ben Daya, Amina Hadjer Radoui, Mohamed Bouchoucha, Rabie Razgallah, Semir Nouira. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 01.03.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Protocol
Ben Hafaiedh, Sonia
Ben Daya, Yosra
Radoui, Amina Hadjer
Bouchoucha, Mohamed
Razgallah, Rabie
Nouira, Semir
Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study)
title Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study)
title_full Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study)
title_fullStr Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study)
title_full_unstemmed Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study)
title_short Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study)
title_sort home telemonitoring of arterial hypertension with antihypertensive treatment titration: protocol for a randomized controlled prospective trial (horoscope study)
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924775/
https://www.ncbi.nlm.nih.gov/pubmed/35230254
http://dx.doi.org/10.2196/26184
work_keys_str_mv AT benhafaiedhsonia hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy
AT bendayayosra hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy
AT radouiaminahadjer hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy
AT bouchouchamohamed hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy
AT razgallahrabie hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy
AT nouirasemir hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy